Microbiological, clinical, and PK/PD features of the new anti-Gram-negative antibiotics: β-lactam/β-lactamase inhibitors in combination and cefiderocol—an all …

L Principe, T Lupia, L Andriani, F Campanile… - Pharmaceuticals, 2022 - mdpi.com
Bacterial resistance mechanisms are continuously and rapidly evolving. This is particularly
true for Gram-negative bacteria. Over the last decade, the strategy to develop new β …

Antimicrobial dose reduction in continuous renal replacement therapy: myth or real need? A practical approach for guiding dose optimization of novel antibiotics

M Gatti, F Pea - Clinical Pharmacokinetics, 2021 - Springer
Acute kidney injury represents a common complication in critically ill patients affected by
septic shock and in many cases continuous renal replacement therapy (CRRT) may be …

Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria

S Zhang, X Liao, T Ding, J Ahn - Antibiotics, 2024 - mdpi.com
Since the discovery of penicillin, β-lactam antibiotics have commonly been used to treat
bacterial infections. Unfortunately, at the same time, pathogens can develop resistance to β …

Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review …

DF Bavaro, A Belati, L Bussini, V Cento… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream
infection (BSI) is a major issue in healthcare, since it is often associated with endocarditis or …

Antimicrobial pharmacokinetics and pharmacodynamics in critical care: Adjusting the dose in extracorporeal circulation and to prevent the genesis of multiresistant …

J Ruiz-Ramos, L Gras-Martín, P Ramírez - Antibiotics, 2023 - mdpi.com
Critically ill patients suffering from severe infections are prone to pathophysiological
pharmacokinetic changes that are frequently associated with inadequate antibiotic serum …

Quantification of ceftaroline in human plasma using high-performance liquid chromatography with ultraviolet detection: application to pharmacokinetic studies

A Alarcia-Lacalle, H Barrasa, J Maynar… - Pharmaceutics, 2021 - mdpi.com
This study was conducted to develop a rapid, simple and reproducible method for the
quantification of ceftaroline in plasma samples by high-performance liquid chromatography …

Pharmacokinetic and Pharmacodynamic Considerations of Novel Antibiotic Agents for Pediatric Infections: A Narrative Review

M Shafiekhani, SA Fatemi, P Hosseini… - Surgical …, 2023 - liebertpub.com
Background: Currently, the escalation of microbial resistance poses a significant global
challenge. Children are more susceptible to develop infections and therefore are prescribed …

Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

A Alarcia-Lacalle, H Barrasa, J Maynar… - Blood …, 2023 - karger.com
Introduction: Continuous renal replacement therapies (CRRTs) are frequently used in
critically ill patients; however, there are scarce in vitro and in vivo studies showing the …

Computer simulations in pharmacokinetics

M Garcia-Cremades, J Aparicio-Blanco… - … -Chemical Aspects of …, 2024 - Elsevier
Computational pharmacokinetic (PK) modeling and simulation are revolutionizing the fields
of drug development and therapeutic use. PK models use mathematical equations to study …

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All …

S Di Bella - Authorea Preprints, 2023 - advance.sagepub.com
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase
Inhibitors in Co Page 1 P osted on 14 Dec 2023 — The cop yrigh t holder is the author/funder …